Monitor U.S. trade policies relating to intellectual property protection under the WTO/TRIPS agreement
health care reform legislation Monitor U.S. trade policies relating to intellectual property protection under the WTO TRIPS agreement
Importation of FDA-approved pharmaceuticals Taxation of International Operations of U.S. corporations generally; R&D tax credit; repatriation of foreign source income; deferral of U.S. taxation of foreign source income; taxation of employer provided healthcare. Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the    
Pan American Health Organization; Childhood immunizations
Dietary supplement issues
Alzheimer's care
Pediatric Studies and Trials
Drug Safety/Clinical Trials
Health care reform legislation
FDA Pre-emption
Follow-on biologics
Drug importation and counterfeiting
Drug advertising
Comparative effectiveness
Physician payment disclosure
Chronic care out of pocket costs
Vaccine Program
H.R. 1427 - Access to Life-Saving Medicine Act
H.R. 1548 - The Pathway for Biosimilars Act
Legislative and regulatory issues related to hormone replacement therapies
International public health issues
International vaccine issues
H.R. 1/S350 - The American Recovery and Reinvestment Act of 2009
H.R. 579 - The Food and Drug Administration Globalization Act
S. 525/H.R. 1298 - The Pharmaceutical Market Access and Drug Safety Act of 2009
S. 301 - Physican Payments Sunshine Act of 2009
H.R. 573 - Authorized Generics
S. 501 - Fair Prescription Drug Competition Act
S. 369 - Preserve Access to Affordable Generics Act
H.R. 1706 - Protecting consumer Access to Generic Drugs Act
S.357 - Sunshine in Litigation Act of 2009
H.R. 3200 - American's Affordable Health Choices Act of 2009
S.1679 Affordable Health Choices Act
S.1213 - Patient Centered Outcomes Research Act of 2009 Vaccines
Medicare chronic disease coverage Implementation Issues concerning P.L. 108-173 - the Medicare Prescription Drug, Improvement and Modernization Act of 2003
Medicare coverage of pharmaceuticals, Medicare Part D
Chronic care out of pocket costs
Medicare Prescription Drug Benefit
Medicaid drug rebate
Medicare and Medicaid Drug Reimbursement
Medicaid Part D Non-Interference
S.301/HR 3138 Physician Payments Sunshine Act of 2009
S.547/H.R. 904 - Drug Rebate Equalization Act of 2009
H.R. 1725 - Voluntary State Discount Prescription Drug Plan Act of 2009
S.330/H.R. 684 - Medicare Prescription Drug Savings and Choice Act of 2009
S.266 - Medicare Prescription Drug Gap Reduction Act of 2009
S.1679 Affordable Health Choices Act FDA reform proposals; Pseudoephedrine
H.R. 1259 DXM Distribution Act Monograph System Reform Proposal
Pseudoephedrine Electronic Log Proposal
S.1383 Dextromethorphan Abuse Reduction Act of 2009
H.R. 2749 Food Safety Enhancement Act of 2009
S. 510 Food Safety Modernization Act of 2009 S. 726/H.R. 1427 - Access to Life-Saving Medicine Act, Follow-on Biologics
H.R. 1548 - The Pathway for Biosimilars Act Biosimilars
Drug Safety
Prescription Drug Importation
Import Safety
Compounding
H.R. 759 - Food and Drug Administration Globaliation Act of 2009
S. 510 - FDA Food Safety Modernization Act
CPT - Copyright/Patent/Trademark TRD - Trade (domestic/foreign) TAX - Taxation/Internal Revenue Code HCR - Health Issues MMM - Medicare/Medicaid CSP - Consumer Issues/Safety/Products PHA - Pharmacy
136 - Centers For Medicare and Medicaid Services (CMS) 11 - Executive Office of the President (EOP) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 37 - Justice, Dept of (DOJ) 127 - Natl Security Agency (NSA) 16 - Natl Security Council (NSC) 1 - SENATE 39 - State, Dept of (DOS) 41 - Treasury, Dept of 22 - U.S. Trade Representative (USTR) 12 - White House Office 136 - Centers For Medicare and Medicaid Services (CMS) 11 - Executive Office of the President (EOP) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 37 - Justice, Dept of (DOJ) 127 - Natl Security Agency (NSA) 16 - Natl Security Council (NSC) 1 - SENATE 39 - State, Dept of (DOS) 41 - Treasury, Dept of 22 - U.S. Trade Representative (USTR) 12 - White House Office 136 - Centers For Medicare and Medicaid Services (CMS) 11 - Executive Office of the President (EOP) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 37 - Justice, Dept of (DOJ) 127 - Natl Security Agency (NSA) 16 - Natl Security Council (NSC) 1 - SENATE 39 - State, Dept of (DOS) 41 - Treasury, Dept of 22 - U.S. Trade Representative (USTR) 12 - White House Office 136 - Centers For Medicare and Medicaid Services (CMS) 11 - Executive Office of the President (EOP) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 37 - Justice, Dept of (DOJ) 127 - Natl Security Agency (NSA) 16 - Natl Security Council (NSC) 1 - SENATE 39 - State, Dept of (DOS) 41 - Treasury, Dept of 22 - U.S. Trade Representative (USTR) 12 - White House Office 136 - Centers For Medicare and Medicaid Services (CMS) 11 - Executive Office of the President (EOP) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 37 - Justice, Dept of (DOJ) 127 - Natl Security Agency (NSA) 16 - Natl Security Council (NSC) 1 - SENATE 39 - State, Dept of (DOS) 41 - Treasury, Dept of 22 - U.S. Trade Representative (USTR) 12 - White House Office 136 - Centers For Medicare and Medicaid Services (CMS) 11 - Executive Office of the President (EOP) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 37 - Justice, Dept of (DOJ) 127 - Natl Security Agency (NSA) 16 - Natl Security Council (NSC) 1 - SENATE 39 - State, Dept of (DOS) 41 - Treasury, Dept of 22 - U.S. Trade Representative (USTR) 12 - White House Office 136 - Centers For Medicare and Medicaid Services (CMS) 11 - Executive Office of the President (EOP) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 37 - Justice, Dept of (DOJ) 127 - Natl Security Agency (NSA) 16 - Natl Security Council (NSC) 1 - SENATE 39 - State, Dept of (DOS) 41 - Treasury, Dept of 22 - U.S. Trade Representative (USTR) 12 - White House Office
WYETH
1667 K STREET NW, #1270, WASHINGTON, DC, 20006, US
JULIE RABINOWITZ LEO C JARDOT BRONWEN KAYE JULIE RABINOWITZ LEO C JARDOT BRONWEN KAYE JULIE RABINOWITZ LEO C JARDOT BRONWEN KAYE LEO C JARDOT JULIE RABINOWITZ ANGELA WALKER RIEMER BRONWEN KAYE LEO C JARDOT JULIE RABINOWITZ ANGELA WALKER RIEMER LEO C JARDOT ANGELA WALKER RIEMER JULIE RABINOWITZ BRONWEN KAYE LEO C JARDOT BRONWEN KAYE JULIE RABINOWITZ ANGELA WALKER RIEMER